Are there metastatic breast cancer clinical trials in Illinois?

Yes. We're currently tracking 100 recruiting metastatic breast cancer studies with a site in Illinois, each rewritten in plain language so you can see what it's testing and who it's for.

How do I find out if I qualify for a metastatic breast cancer study in Illinois?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in Illinois to take part?

Not necessarily. These studies have a site in Illinois, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a metastatic breast cancer trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · Illinois

Metastatic Breast Cancer clinical trials in Illinois

We’re tracking 100 recruiting metastatic breast cancer studies with a site in Illinois — including Phase 1, Phase 2 and Phase 3 studies, each written for real people, not researchers.

Recruiting studies in Illinois

NCT04389632RecruitingPhase 1
Sigvotatug vedotin for advanced solid tumors that spread
This early-stage study tests a drug called sigvotatug vedotin in people with advanced solid cancers that cannot be removed or have spread. It aims to see how well the treatment works and what side effects it causes.
Flossmoor, IllinoisAges 18 years+
NCT05687110RecruitingPhase 1
Testing novobiocin for tumors with DNA repair gene changes
This Phase 1 study tests whether novobiocin is safe and finds the best dose for people whose tumors have specific DNA repair gene mutations. It may help if your cancer is hard to treat with standard options, including certain patients who already tried PARP inhibitors.
Chicago, IllinoisAges 18 years+
NCT06422806RecruitingPhase 3
Immunotherapy plus chemo for aggressive sarcoma
This trial compares a combination of immunotherapy (pembrolizumab) plus chemotherapy (doxorubicin) versus chemotherapy alone for people with aggressive, poorly differentiated sarcomas that have spread or cannot be removed. The goal is to see if adding immunotherapy helps shrink tumors or slow their growth better than chemotherapy alone.
Aurora, IllinoisAges 18 years+
NCT04665739RecruitingPhase 2
Lutetium Lu-177 for lung carcinoid tumors with somatostatin receptors
This trial tests lutetium Lu 177 dotatate, a targeted radiation treatment, for advanced lung neuroendocrine (carcinoid) tumors that have a specific marker called somatostatin receptors. It may help shrink tumors by delivering radiation directly to cancer cells that “light up” on a special scan.
Chicago, IllinoisAges 18 years+

Metastatic Breast Cancer trials by city in Illinois

Chicago

Where these studies are running in Illinois

Institutions with a site for the recruiting metastatic breast cancer studies listed above.

University of Chicago · 4 studies
UC Comprehensive Cancer Center at Silver Cross · 3 studies
University of Chicago Medicine-Orland Park · 3 studies
Ingalls Memorial Hospital · 2 studies
Southern Illinois University School of Medicine · 2 studies
Springfield Clinic · 2 studies
Springfield Memorial Hospital · 2 studies
Advocate Christ Medical Center

What taking part in a metastatic breast cancer study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Metastatic Breast Cancer trials in other states

Common questions

Are there metastatic breast cancer clinical trials in Illinois?: Yes. We're currently tracking 100 recruiting metastatic breast cancer studies with a site in Illinois, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a metastatic breast cancer study in Illinois?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in Illinois to take part?: Not necessarily. These studies have a site in Illinois, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a metastatic breast cancer trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New metastatic breast cancer studies open in Illinois regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.